{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:12Z","timestamp":1794435912733,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.semnuclmed.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:37:24Z","timestamp":1786131444000},"page":"905-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroblastoma imaging: From MIBG to advanced PET tracers"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-992X","authenticated-orcid":false,"given":"Ameya D.","family":"Puranik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.008_bib0001","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/jso.28076","article-title":"Adults and adolescents with Neuroblastoma: an analysis of the national cancer database","volume":"131","author":"Chidiac","year":"2025","journal-title":"J Surg Oncol"},{"issue":"S6","key":"10.1053\/j.semnuclmed.2026.07.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30572","article-title":"Children\u2019s oncology group\u2019s 2023 blueprint for research: neuroblastoma","volume":"70","author":"Bagatell","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.008_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11912-009-0059-6","article-title":"Neuroblastoma: biology and staging","volume":"11","author":"Mueller","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.semnuclmed.2026.07.008_bib0004","series-title":"An Overview of Neuroblastoma","first-page":"5","author":"Moyes","year":"1989"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1148\/rg.2016150099","article-title":"MIBG in Neuroblastoma diagnostic imaging and therapy","volume":"36","author":"Sharp","year":"2016","journal-title":"RadioGraphics"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/ijnm.ijnm_10_21","article-title":"123I\u2013meta\u2013iodobenzylguanidine single\u2013photon emission computerized tomography\/computerized tomography scintigraphy in the management of Neuroblastoma","volume":"36","author":"Biassoni","year":"2021","journal-title":"Indian J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0007","first-page":"53","article-title":"131I\u2013Metaiodobenzylguanidine therapy in children with advanced Neuroblastoma","volume":"57","author":"Dubois","year":"2013","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0008","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1148\/radiol.2442072524","article-title":"Positron emission tomography: clinical practice","volume":"244","author":"Valk","year":"2007","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/jpm11040270","article-title":"Nuclear medicine imaging in Neuroblastoma: current status and new developments","volume":"11","author":"Samim","year":"2021","journal-title":"JPM"},{"issue":"18","key":"10.1053\/j.semnuclmed.2026.07.008_bib0010","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2174\/138161206777585193","article-title":"Molecularly guided therapy of Neuroblastoma: a review of different approaches","volume":"12","author":"Tonini","year":"2006","journal-title":"CPD"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/1545-5017.70180","article-title":"Imaging of high\u2013risk Neuroblastoma: recommendations from SIOPEN radiology and nuclear medicine specialty committees","volume":"73","author":"Littooij","year":"2026","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0012","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2231010841","article-title":"Staging of Neuroblastoma at imaging: report of the radiology diagnostic oncology group","volume":"223","author":"Siegel","year":"2002","journal-title":"Radiology"},{"issue":"S4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29974","article-title":"Imaging of pediatric Neuroblastoma: a COG diagnostic imaging committee\/SPR oncology committee white paper","volume":"70","author":"Lai","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0971-3026.155844","article-title":"Imaging in Neuroblastoma: an update","volume":"25","author":"Kembhavi","year":"2015","journal-title":"Indian J Radiol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.008_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1542\/pir.12.7.196","article-title":"Abdominal masses in children: neuroblastoma, wilms tumor, and other considerations","volume":"12","author":"Brodeur","year":"1991","journal-title":"Pediatr Rev"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0016","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00004728-198208000-00024","article-title":"CT features of calcification in abdominal Neuroblastoma","volume":"6","author":"Araki","year":"1982","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0017","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00431-023-04899-0","article-title":"Association of image\u2013defined risk factors with clinical features, tumor biology, and outcomes in Neuroblastoma: a single\u2013center retrospective study","volume":"182","author":"Yang","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0018","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00247-022-05489-2","article-title":"Imaging in Neuroblastoma","volume":"53","author":"Littooij","year":"2022","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0019","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3109\/02841859909175580","article-title":"Imaging of abdominal Neuroblastoma in children","volume":"40","author":"Hugosson","year":"1999","journal-title":"Acta Radiol"},{"issue":"04","key":"10.1053\/j.semnuclmed.2026.07.008_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0036-1572362","article-title":"Metaiodobenzylguanidine and Neuroblastoma","volume":"05","author":"Loaiza","year":"2016","journal-title":"J Pediatr Biochem"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0021","first-page":"186","article-title":"Biology of metaiodobenzylguanidine interactions with human Neuroblastoma cells","volume":"35","author":"Iavarone","year":"1991","journal-title":"J Nucl Biol Med"},{"key":"10.1053\/j.semnuclmed.2026.07.008_bib0022","doi-asserted-by":"crossref","unstructured":"Muckle M. I\u2013MIBG SPECT\/CT for Tumour Imaging. In Springer Berlin Heidelberg; 2013. p. 111\u2013127.","DOI":"10.1007\/978-3-642-35283-6_6"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.07.008_bib0023","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","article-title":"131I\/123I\u2013metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4274\/mirt.52533","article-title":"Qazi A. I\u2013131 mIBG scintigraphy curie versus siopen scoring: prognostic value in stage 4 Neuroblastoma","volume":"27","author":"Riaz","year":"2018","journal-title":"Mirt"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.008_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/RLU.0000000000006372","article-title":"Prognostic value of semi\u2013quantitative score based on 123I\u2013MIBG SPECT\/CT in Chinese pediatric patients with stage 4 high\u2013risk Neuroblastoma after induction therapy","volume":"51","author":"Wang","year":"2026","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30418","article-title":"Impact of diagnostic and end\u2013of\u2013induction Curie scores with tandem high\u2013dose chemotherapy and autologous transplants for metastatic high\u2013risk Neuroblastoma: a report from the children\u2019s oncology group","volume":"70","author":"Streby","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0027","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12149-021-01595-7","article-title":"123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of Neuroblastoma using semi\u2013quantitative SPECT\/CT analysis","volume":"35","author":"Kitamura","year":"2021","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0028","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11596-017-1785-x","article-title":"Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with Neuroblastoma: systemic review and meta\u2013analysis","volume":"37","author":"Xia","year":"2017","journal-title":"Curr Med Sci"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12149-014-0813-1","article-title":"18F\u2013FDG PET as a single imaging modality in pediatric Neuroblastoma: comparison with abdomen CT and bone scintigraphy","volume":"28","author":"Choi","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.008_bib0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/pbc.21594","article-title":"Utility of FDG\u2013PET\/CT in the follow\u2013up of Neuroblastoma which became MIBG\u2013negative","volume":"51","author":"Colavolpe","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.008_bib0031","first-page":"1","article-title":"Diagnostic performance of 18F\u2013FDG PET(CT) in bone\u2013bone marrow involvement in pediatric Neuroblastoma: a systemic review and meta\u2013analysis","volume":"2021","author":"Sun","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.008_bib0032","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.108.060467","article-title":"123I\u2013MIBG scintigraphy and 18F\u2013FDG PET in Neuroblastoma","volume":"50","author":"Sharp","year":"2009","journal-title":"J Nucl Med"},{"issue":"22","key":"10.1053\/j.semnuclmed.2026.07.008_bib0033","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2016.72.0177","article-title":"Revisions to the international Neuroblastoma response criteria: a consensus statement from the national cancer institute clinical trials planning meeting","volume":"35","author":"Park","year":"2017","journal-title":"JCO"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0034","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPH.0000000000001326","article-title":"Prevalence and clinical correlations of somatostatin receptor\u20132 (SSTR2) expression in Neuroblastoma","volume":"41","author":"Alexander","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.semnuclmed.2026.07.008_bib0035","first-page":"1","article-title":"Correlation of somatostatin receptor\u20132 expression with gallium\u201368\u2013DOTA\u2013TATE uptake in Neuroblastoma xenograft models","volume":"2017","author":"Zhang","year":"2017"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0036","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnmt.122.264694","article-title":"68Ga\u2013DOTATATE PET in restaging and response to therapy in Neuroblastoma: a case series and a mini review","volume":"51","author":"Alsadi","year":"2023","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0037","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-010-1720-x","article-title":"Functional imaging in phaeochromocytoma and Neuroblastoma with 68Ga\u2013DOTA\u2013Tyr3\u2013octreotide positron emission tomography and 123I\u2013metaiodobenzylguanidine","volume":"38","author":"Kroiss","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0038","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2967\/jnmt.120.258939","article-title":"68Ga\u2013DOTATATE PET\/CT for Neuroblastoma staging: utility for clinical use","volume":"49","author":"Maaz","year":"2021","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0039","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00259-025-07399-5","article-title":"68Ga]Ga\u2013DOTA\u2013TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric Neuroblastoma imaging: a prospective study","volume":"53","author":"Liu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.07.008_bib0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11864-019-0678-6","article-title":"Molecular imaging and therapy for Neuroendocrine tumors","volume":"20","author":"Desai","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0041","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1109\/TRPMS.2022.3201757","article-title":"Simultaneous imaging of Ga\u2013DOTA\u2013TATE and Lu\u2013DOTA\u2013TATE in murine models of Neuroblastoma","volume":"7","author":"Zheng","year":"2023","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0042","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2967\/jnumed.120.243139","article-title":"124I\u2013MIBG PET\/CT to monitor metastatic disease in children with relapsed Neuroblastoma","volume":"62","author":"Aboian","year":"2020","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0043","first-page":"21","article-title":"Quantitative imaging of (124)I with PET\/CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections","volume":"55","author":"Jentzen","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"Suppl 15","key":"10.1053\/j.semnuclmed.2026.07.008_bib0044","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/JCO.2018.36.15_suppl.4005","article-title":"Azedra (iobenguane I 131) in patients with malignant, recurrent and\/or unresectable pheochromocytoma or paraganglioma (PPGL): updated efficacy and safety results from a multi\u2013center, open\u2013label, pivotal phase 2 study","volume":"36","author":"Pryma","year":"2018","journal-title":"JCO"},{"issue":"Suppl 1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4274\/2017.26.suppl.07","article-title":"I\u2013124 Imaging and Dosimetry","volume":"26","author":"Kuker","year":"2017","journal-title":"Mirt"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0046","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00259-025-07490-x","article-title":"Comprehensive analysis of [18F]MFBG biodistribution normal patterns and variability in pediatric patients with Neuroblastoma","volume":"53","author":"Wang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0047","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00259-022-06046-7","article-title":"18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients","volume":"50","author":"Pauwels","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.008_bib0048","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00259-022-06063-6","article-title":"18F]mFBG PET\u2013CT for detection and localisation of Neuroblastoma: a prospective pilot study","volume":"50","author":"Samim","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0049","article-title":"[18F]mFBG PET\/CT surpasses [18F]FDG PET\/CT for evaluation of pediatric Neuroblastoma","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00259-025-07449-y","article-title":"18F]MFBG PET\/CT is an effective and preferable imaging modality for Neuroblastoma in a prospective comparison with SSTR PET","volume":"53","author":"Wang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.008_bib0051","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40336-016-0162-2","article-title":"Potential role of 18F\u2013DOPA PET in Neuroblastoma","volume":"4","author":"Piccardo","year":"2016","journal-title":"Clin Transl Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.008_bib0052","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s13139-022-00762-6","article-title":"Comparative role of 18F\u2013DOPA PET\/CT and 131I\u2013MIBG scintigraphy in Neuroblastoma and application of curie and SIOPEN scoring systems in 18F\u2013DOPA PET\/CT","volume":"56","author":"Hemrom","year":"2022","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0053","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/10935266251325632","article-title":"Evaluating bone marrow involvement in pediatric Neuroblastoma: traditional methods and emerging technologies\u2013a systematic review","volume":"28","author":"Singh","year":"2025","journal-title":"Pediatr Dev Pathol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.008_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30983","article-title":"Feasibility of 18F\u2013DOPA and 18F\u2013FDG PET\/CT for guiding decision\u2013making for localized incidental Neuroblastoma in infants under 18months of age","volume":"71","author":"Hung","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.008_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40644-024-00718-3","article-title":"Whole\u2013tumoral metabolic heterogeneity in 18F\u2013FDG PET\/CT is a novel prognostic marker for Neuroblastoma","volume":"24","author":"Liu","year":"2024","journal-title":"Cancer Imaging"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.07.008_bib0056","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1007\/s00261-025-04973-1","article-title":"18F\u2013FDG PET\/CT volumetric parameter predicts prognosis for Neuroblastoma with MYCN gain","volume":"50","author":"Li","year":"2025","journal-title":"Abdom Radiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.008_bib0057","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.119.232553","article-title":"Diagnosis, treatment response, and prognosis: the role of 18F\u2013DOPA PET\/CT in Children affected by Neuroblastoma in Comparison with 123I\u2013mIBG scan: the first prospective study","volume":"61","author":"Piccardo","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:28:12Z","timestamp":1794432492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0001299826001467"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.07.008","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroblastoma imaging: From MIBG to advanced PET tracers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}